HPLC Determination and Pharmacokinetic Profile of Procainamidein Korean Subjects |
Bae Jung-Woo
(Lab. of Pharmacology, College of Pharmacy, Sungkyunkwan University)
Kim Hyun-Kyung (Lab. of Pharmacology, College of Pharmacy, Sungkyunkwan University) Yang Sang-In (Lab. of Pharmacology, College of Pharmacy, Sungkyunkwan University) Kim Ji-Hong (Lab. of Pharmacology, College of Pharmacy, Sungkyunkwan University) Kim Kyung-Hye (Lab. of Pharmacology, College of Pharmacy, Sungkyunkwan University) Jang Choon-Gon (Lab. of Pharmacology, College of Pharmacy, Sungkyunkwan University) Park Young-Seo (Dept. Pediatrics, University of Ulsan College of Medicine, Asan Medical Center) Sohn Uy-Dong (College of Pharmacy, Chung-Ang University) Lee Seok-Yong (Lab. of Pharmacology, College of Pharmacy, Sungkyunkwan University) |
1 | Giardina, E. G. : Procainamide: clinical pharmacology and efficacy against ventricular arrhythmias. Ann. N. Y. Acad. Sci. 432, 177 (1984) DOI PUBMED |
2 | Dutcher, J. S., Strong, J. M., Lucas, S. V., Lee, W. K. and Atkinson, A. J. Jr. : Procainamide and N-acetylprocainamide kinetics investigated simultaneously with stable isotype methodology. Clin. Pharmacol. Ther. 22, 447 (1977) DOI |
3 | Gibson, T. P., Lowenthal, D. T., Nelson, H. A. and Briggs, W. A. : Elimination of procainamide in end stage renal failure. Clin. Pharmacol. Ther. 17, 321 (1975) DOI |
4 | Gibson, T. P., Matusik, E. J. and Briggs W. A. : N-Acetylprocainamide levels in patients with end-stage renal failure. Clin. Pharmacal. Ther. 19, 206 (1976) DOI |
5 | Dollery, C. : The Therapeutic Drugs. 2nd ed. Churchill Livingstone, London, p. P215 (1999) |
6 | Du Souich, P. and Erill, S. : Metabolism of procainamide in patients with chronic heart failure, chronic respiratory failure and chronic renal failure. Eur. J. Clin. Pharmacal. 14, 21 (1978) DOI ScienceOn |
7 | Lessard, E., Fortin, A., Coquet, A., Belanger, P. M., Hamelin, B. A. and Turgeon, J. : Improved high-performance liquid chromatographic assy for the determination of procainamide and its N-acetylated metabolite in plasma: application to a single-dose pharmacokinetics study. J. Chromatagr. Sci. 36, 49 (1998) DOI ScienceOn |
8 | Giardina, E. G., Dreyfuss, J., Bigger, J. T., Shaw, J. M. and Schreiber, E. C. : Metabolism of procainamide in normal and cardiac subjects. Clin. Pharmacol. Ther. 19, 339 (1976) DOI |
9 | Reidenberg, M. M., Drayer, D. E., Levy, M. and Warner, H. : Polymorphic acetylation procainamide in man. Clin. Pharmacal. Ther. 17, 722 (1975) DOI |
10 | Coyle, J. D., MacKichan, J. J., Boudoulas, H. and Lima, J. J. : Reverse-phase liquid chromatography method for measurment of procainamide and three metabolites in serum and urine: precent of dose excreted as deethyl metabolites.J. Pharm. Sci. 76, 402 (1987) DOI |
11 | Katzung, B. G. : Basic and Clinical Pharmacology. 8th ed., McGraw-Hill Inc., NY, p. 231 (2001) |
12 | Gibson, T. P., Atkinson, A. J. Jr., Matusik, E., Nelson, L. D. and Briggs, W. A. : Kinetics od procainamide and N-acetylprocainamide in renal failure. Kidney Int. 12, 422 (1977) DOI ScienceOn |
13 | Jamali, F., AIballa, R. S., Mehvar, R. and Lemko, C. H. : Longer plasma half-life procainamide utilizing a very sensitive high performance liquid chromatography assay. Ther. Drug. Monit. 10, 91 (1988) DOI |